CIK: 0001687807
Total reported value
$87.4M
Reporting period: 2018-12-31 · Number of holdings: 41
Diag Capital Management, LP disclosed 41 holdings in its latest 13F filing for the period ending 2018-12-31, with total reported value of $87.4M and a quarterly turnover rate of 0.0%.
Browse other institutions with under $100M AUMBrowse other institutions starting with "D"
Diag Capital Management, LP's disclosed holdings carry a Herfindahl concentration index of 0.038 — mathematically equivalent to about 27 equally-sized positions, close to its 41 actual disclosed holdings. Value is spread relatively evenly across the portfolio rather than concentrated in a handful of names.
Position sizes are fairly uniform across the portfolio (a coefficient of variation of 0.72), suggesting a disciplined, rules-based approach to how much capital goes into each idea.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 15% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
No holding changes this quarter
Showing top 40 holdings (of 41 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | BAX | Baxter International INC | Stock-Healthcare | 6.47% | — | — | — |
| 2 | ATNXEUR | Athenex INC | Stock-Other | 6.23% | — | — | — |
| 3 | ZBH | Zimmer Biomet Holdings INC | Stock-Healthcare | 5.66% | — | — | — |
| 4 | ABBV | Abbvie INC | Stock-Healthcare | 5.32% | — | — | — |
| 5 | INCY | Incyte CORP | Stock-Healthcare | 5.25% | — | — | — |
| 6 | QTRX | Quanterix CORP | Stock-Other | 4.69% | — | — | — |
| 7 | CELG | Celgene CORP | Stock-Other | 4.63% | — | — | — |
| 8 | AMGN | Amgen INC | Stock-Healthcare | 4.48% | — | — | — |
| 9 | MDT | Medtronic plc | Stock-Healthcare | 3.76% | — | — | — |
| 10 | ✓ | Quotient LTD | Stock-Other | 3.69% | — | — | — |
| 11 | PCRX 3.25 02-01-19 | Pacira Pharmaceuticals | Stock-Other | 3.67% | — | — | — |
| 12 | TAK | Takeda Pharmaceutic-sp Adr | Stock-Healthcare | 3.41% | — | — | — |
| 13 | ABT | Abbott Laboratories | Stock-Healthcare | 3.19% | — | — | — |
| 14 | ZLAB | Zai Lab Ltd-adr | Stock-Other | 3.19% | — | — | — |
| 15 | ✓ | Mylan N V | Stock-Other | 3.12% | — | — | — |
| 16 | COOL1EUR | Polarityte INC | Stock-Other | 2.82% | — | — | — |
| 17 | VRAYQ | Viewray INC | Stock-Other | 2.76% | — | — | — |
| 18 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 2.47% | — | — | — |
| 19 | TEVA | Teva Pharmaceutical-sp Adr | Stock-Healthcare | 2.46% | — | — | — |
| 20 | AKRXEUR | Akorn INC | Stock-Other | 2.46% | — | — | — |
| 21 | HAE | Haemonetics Corp/mass | Stock-Other | 2.43% | — | — | — |
| 22 | ARGX | Argenx Se - Adr | Stock-Healthcare | 1.84% | — | — | — |
| 23 | BHVN | Biohaven Ltd. | Stock-Other | 1.62% | — | — | — |
| 24 | MMSI | Merit Medical Systems INC | Stock-Healthcare | 1.60% | — | — | — |
| 25 | SNY | Sanofi-adr | Stock-Healthcare | 1.50% | — | — | — |
| 26 | GWPH | Gw Pharmaceuticals LTD | Stock-Other | 1.50% | — | — | — |
| 27 | LIVN | LivaNova PLC | Stock-Other | 1.25% | — | — | — |
| 28 | ✓ | Molecular Templates Inc | Stock-Other | 1.13% | — | — | — |
| 29 | ✓ | Foamix Pharmaceuticals LTD | Stock-Other | 1.10% | — | — | — |
| 30 | ✓ | Verrica Pharmaceuticals INC | Stock-Other | 1.07% | — | — | — |
| 31 | NBIX | Neurocrine Biosciences INC | Stock-Healthcare | 1.00% | — | — | — |
| 32 | XRAY | Dentsply Sirona INC | Stock-Healthcare | 0.87% | — | — | — |
| 33 | AXNX* | Axonics INC | Stock-Other | 0.80% | — | — | — |
| 34 | ✓ | Arya Sciences Acquisition Co | Stock-Other | 0.60% | — | — | — |
| 35 | ADMA | Adma Biologics INC | Stock-Healthcare | 0.50% | — | — | — |
| 36 | MDGL | Madrigal Pharmaceuticals INC | Stock-Healthcare | 0.37% | — | — | — |
| 37 | ARVN | Arvinas INC | Stock-Other | 0.36% | — | — | — |
| 38 | NVAX 3.75 02-01-23 | Novavax INC | Stock-Healthcare | 0.33% | — | — | — |
| 39 | NEOS | Neos Therapeutics INC | Stock-Other | 0.32% | — | — | — |
| 40 | ANAB | Anaptysbio INC | Stock-Other | 0.11% | — | — | — |
Not enough priced holdings yet to compute performance
Not enough data yet to compute personality scores
Not enough sector-mapped data yet
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2018-12-31 | 2019-02-14 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0001636441
Total reported value
$87.4M
11 stks
2026-03-31
AUM within 0.0% of this institution
CIK 0001524467
Total reported value
$87.5M
34 stks
2013-12-31
Stale — no recent filing
AUM within 0.0% of this institution
CIK 0001461564
Total reported value
$87.4M
81 stks
2019-03-31
Stale — no recent filing
AUM within 0.0% of this institution
Institutions with overlapping top holdings
CIK 0001444043
Total reported value
$1.1B
25 stks
2025-06-30
Stale — no recent filing
2 of the top 5 holdings overlap, including Zimmer Biomet Holdings INC
CIK 0002058325
Total reported value
$192.9M
24 stks
2026-06-30
2 of the top 5 holdings overlap, including Zimmer Biomet Holdings INC
CIK 0000012933
Total reported value
$622.0M
398 stks
2022-12-31
Stale — no recent filing
1 of the top 5 holdings overlap, including Abbvie INC